Europlasma SA
PAR:ALEUP
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.29
103.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
ALEUP
stock under the Base Case scenario is
62.95
EUR.
Compared to the current market price of 0.29 EUR,
Europlasma SA
is
Undervalued by 100%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
| US |
|
Waste Management Inc
NYSE:WM
|
|
| US |
|
Republic Services Inc
NYSE:RSG
|
|
| CA |
|
Waste Connections Inc
TSX:WCN
|
|
| US |
|
Rollins Inc
NYSE:ROL
|
|
| US |
|
Veralto Corp
NYSE:VLTO
|
|
| CA |
|
GFL Environmental Inc
TSX:GFL
|
|
| UK |
|
Rentokil Initial PLC
LSE:RTO
|
|
| US |
|
Clean Harbors Inc
NYSE:CLH
|
|
| US |
|
Tetra Tech Inc
NASDAQ:TTEK
|
|
| CN |
|
Spic Yuanda Environmental Protection Co Ltd
SSE:600292
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Europlasma SA
Balance Sheet Decomposition
Europlasma SA
| Current Assets | 38.7m |
| Cash & Short-Term Investments | 1.7m |
| Receivables | 16.7m |
| Other Current Assets | 20.2m |
| Non-Current Assets | 24.2m |
| Long-Term Investments | 4.4m |
| PP&E | 19.5m |
| Intangibles | 280k |
| Other Non-Current Assets | 17k |
| Current Liabilities | 50.3m |
| Accounts Payable | 11.2m |
| Accrued Liabilities | 7.1m |
| Short-Term Debt | 1.8m |
| Other Current Liabilities | 30.1m |
| Non-Current Liabilities | 23m |
| Long-Term Debt | 10.2m |
| Other Non-Current Liabilities | 12.8m |
Free Cash Flow Analysis
Europlasma SA
| EUR | |
| Free Cash Flow | EUR |
Earnings Waterfall
Europlasma SA
|
Revenue
|
42.5m
EUR
|
|
Cost of Revenue
|
-30.1m
EUR
|
|
Gross Profit
|
12.4m
EUR
|
|
Operating Expenses
|
-38.6m
EUR
|
|
Operating Income
|
-26.3m
EUR
|
|
Other Expenses
|
11m
EUR
|
|
Net Income
|
-15.3m
EUR
|
ALEUP Profitability Score
Profitability Due Diligence
Europlasma SA's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Europlasma SA's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
ALEUP Solvency Score
Solvency Due Diligence
Europlasma SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Score
Europlasma SA's solvency score is 28/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALEUP Price Targets Summary
Europlasma SA
Dividends
Current shareholder yield for
ALEUP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?